Quantcast

Latest Ablynx Stories

2014-03-05 04:22:20

DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/885sfr/bispecific ) has announced the addition of the "Concise Analysis of the International Bispecific Antibody Therapeutics Market" [http://www.researchandmarkets.com/research/885sfr/bispecific ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Antibody based therapeutics are the fastest growing segment of the drugs and...

2011-01-12 18:16:42

Discovery means breakthrough for the development of new drugs based on GPCR's Adrenaline, the hormone that prepares our body to fight or flight, acts on a hyperdynamic receptor. This molecule switches so fast between several positions, that it was impossible to image it. Until now. Scientists, including Jan Steyaert of VIB and the Vrije Universiteit Brussel in Belgium, and colleagues from Stanford University in the US, have "frozen the molecule in action" using...

2010-03-25 09:00:00

Symposium will Present the Latest Research in Biopharmaceutical Drug Discovery DANBURY, Conn., March 25 /PRNewswire-USNewswire/ -- The Society for Biomolecular Sciences (SBS) will present Biopharmaceuticals: Exploring Synergies Across Drug Formats at the San Francisco Hilton Union Square in San Francisco on May 20-21, 2010. Biopharmaceuticals is one of the fastest growing sectors of the pharmaceutical industry. This two-day meeting will explore the latest synergies between small molecule...

2009-10-26 07:30:00

RALEIGH, N.C., Oct. 26 /PRNewswire/ -- Most Successful Early Phase Trial -- PRA International, a leading Clinical Research Organization, is pleased to announce that a study it has been conducting for one of its customers was awarded the "Most Successful Early Phase Trial" at the 2009 Good Clinical Practice Journal's (GCPj) Clinical Research Excellence Awards in London. The GCPj Awards recognize and reward corporate and individual excellence in clinical research, involving partnerships...

2008-10-06 12:00:30

Ablynx, a biopharmaceutical company focused on the discovery and development of nanobodies, has received a grant worth E1.8 million from the Institute for the Promotion of Innovation by Science and Technology in Flanders. The grant, which is over three years, allows Ablynx to further develop technologies related to its Nanobody platform. Furthermore, this grant will enable Ablynx to expand its intellectual property portfolio. Edwin Moses, CEO and chairman of Ablynx, said: "We are...

1f5f20ccf84ea9e4eb75ca859981bbb21
2008-09-12 12:44:49

The head of biotech research GlaxoSmithKline Plc said a new generation of "slimline" antibody medicines may be successors to current blockbusters such as Avastin and Rituxan. Ian Tomlinson headed the next-generation antibody firm Domantis until Glaxo bought it for $405 million in 2006. Now a coming wave of ultra-small antibody products capable of working in ways impossible for conventional treatments is gaining attention. Tomlinson said he thinks the next generation approaches have tremendous...

2008-09-05 09:00:38

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has entered into an agreement with Ablynx, to co-discover and co-develop Nanobodies against two targets in oncology and immunology. The agreement includes an upfront cash payment to Ablynx of E10 million. Nanobodies are a new class of therapeutic proteins that contain the unique structural and functional properties of naturally occurring single domain antibodies. The partners will collaborate to research and develop...

2008-09-04 03:00:25

Ablynx and Merck Serono to equally contribute to discover and develop Nanobodies(R) against two targets in oncology and immunology and equally share the resulting profits Ghent, BELGIUM, 4 September 2008 - Ablynx [Euronext Brussels: ABLX], a pioneer in the discovery and development of Nanobodies(R), a novel class of antibody-derived therapeutic proteins, today announced that it has entered into an agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, to...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related